Quest Diagnostics: Should You Invest in This Top-Ranked Growth Stock?

Quest Diagnostics (DGX) is a top-ranked growth stock with a strong Zacks Rank and VGM Score. Its Value Score is A, indicating a low P/E ratio and high cash flow per share. The Growth Score is B, with projected earnings growth of 9.2% and sales growth of 8.1%. The Momentum Score is also B, with a one-week price change of 1.1% and a monthly earnings estimate revision of 1.7%. Overall, DGX is a solid investment choice for those seeking growth and value.